Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden

J Infect Dis. 1998 Apr;177(4):1097-100. doi: 10.1086/517403.

Abstract

The majority of vertical infections with human immunodeficiency virus type 1 (HIV-1) occur at or near delivery, strongly suggesting a mucosal route of transmission. The frequency and level of intrapartum mucosal exposure to HIV-1 of 22 infants born to infected mothers was investigated. Maternal plasma HIV-1 RNA and CD4 cell count were measured at delivery. Infant oropharyngeal aspirates obtained at birth were examined for HIV-1 RNA by reverse transcription-polymerase chain reaction and qualitative nucleic acid sequence-based amplification. Nine infants (41%) had detectable levels of HIV-1 RNA, 3 of which were quantifiable (mean, 3000 copies/mL). This mucosal exposure to HIV-1 during delivery did not lead to infection of any infant. Cesarian delivery did not reduce mucosal exposure to HIV-1. Mucosal exposure did not correlate with maternal CD4 cell count but did correlate with maternal plasma virus load and was reduced by antiretroviral therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Cesarean Section / adverse effects
  • Female
  • HIV Infections / transmission*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification*
  • Humans
  • Infant
  • Infectious Disease Transmission, Vertical
  • Mouth Mucosa / virology*
  • Oropharynx / virology
  • Polymerase Chain Reaction
  • Pregnancy
  • Pregnancy Complications, Infectious / virology
  • RNA, Viral / isolation & purification*

Substances

  • RNA, Viral